OTC MiraLAX Must Contend With Prescription Competition – Court
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough failed to force firms offering Rx equivalents to MiraLAX laxative, which S-P markets as an OTC product, to stop using "prescription only" claims for their products, according to a federal court ruling